PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

91 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
41.
De-Colle, C.* et al.: SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy. Radiother. Oncol. 126, 125-131 (2018)
42.
Forster, C.* ; Schilling, D. ; Wank, M. ; Schmid, T.E. & Combs, S.E.: Effects of the proteasome inhibitor bortezomib on radiosensitivity of glioblastoma cells. Radiother. Oncol. 127, S1281-S1282 (2018)
43.
Gora, T.* et al.: Detection of radiation induced lung fibrosis using x-ray dark-field imaging in a murine model. Radiother. Oncol. 127, E581-E582 (2018)
44.
Hofmeister, A.* et al.: Reduction of lung dose during stereotactic radiation of lung tumors using respiratory gating. Radiother. Oncol. 127, S758-S759 (2018)
45.
Kessel, K.A. et al.: Tomotherapy of pediatric sarcomas: Outcome and toxicity rates. Radiother. Oncol. 127, S610-S611 (2018)
46.
Kessel, K.A. et al.: Cancer Clinical Trials - survey evaluating patient participation and attitude in an Oncology Center. Radiother. Oncol. 127, S50-S50 (2018)
47.
Kessel, K.A. ; Bihoi, G.A.* ; Oechsner, M.* ; Duma, M.N.* & Combs, S.E.: Influence of dose applied to cochlea during RT of vestibular schwannoma and its effect on hearing. Radiother. Oncol. 127, S636-S637 (2018)
48.
Klymenko, O. et al.: HNSCC derived cell lines and subclones differ in genomic copy number changes and radiation response. Radiother. Oncol. 127, S1266-S1267 (2018)
49.
Linge, A.* et al.: Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC. Radiother. Oncol. 127, 27-35 (2018)
50.
Martin, F.* et al.: Downregulation of ALDH1A1 reduces radioresistance and migration of glioblastoma cells. Radiother. Oncol. 127, S1283-S1283 (2018)
51.
Mueller, B.S.* et al.: Dosimetric impact of stabilizing spinal implants in proton therapy: Titanium vs. carbon systems. Radiother. Oncol. 127, S1052-S1053 (2018)
52.
Schilling, D. ; Herold, B.* ; Combs, S.E. & Schmid, T.E.: Selenium does not affect radiosensitivity of human breast cancer cell lines. Radiother. Oncol. 127, S1271-S1271 (2018)
53.
Schmidt, A.A.* ; Kessel, K.A.* ; Duma, M.N.* & Combs, S.E.: 15 years of cerebral stereotactic radiotherapy at the Klinikum rechts der Isar, Munich. Radiother. Oncol. 127, S659-S660 (2018)
54.
Schoetz, U.* et al.: Prognostic biomarkers and targets for personalization of radiotherapy of HNSCC: CD44v6. Radiother. Oncol. 127, S251-S251 (2018)
55.
Adeberg, S.* et al.: Sequential proton boost after standard chemoradiation for high-grade glioma. Radiother. Oncol. 125, 266-272 (2017)
56.
Friedland, W. & Kundrát, P.: Stochastic multi-scale modelling of biological effects induced by ionizing radiation. In: (El Naqa, I [Ed.]: A guide to outcome modeling in radiotherapy and oncology). 2017. 147-180 (Radiother. Oncol.)
57.
Hofmaier, J.* et al.: Multi-criterial patient positioning based on dose recalculation on scatter-corrected CBCT images. Radiother. Oncol. 125, 464-469 (2017)
58.
Linge, A.* et al.: HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiother. Oncol. 121, 364-373 (2016)
59.
Niyazi, M.* et al.: ESTRO-ACROP guideline "target delineation of glioblastomas". Radiother. Oncol. 118, 35-42 (2016)
60.
Sage, E.K.* et al.: Comparative analysis of the effects of radiotherapy versus radiotherapy after adjuvant chemotherapy on the composition of lymphocyte subpopulations in breast cancer patients. Radiother. Oncol. 118, 176-180 (2016)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮